Athenex, Inc. financial data

Industry
Pharmaceutical Preparations
Location
1001 Main Street, Suite 600, Buffalo, NY
State of incorporation
DE
Fiscal year end
December 31
Former names
Kinex Pharmaceuticals, Inc. (to 6/16/2015), Kinex Pharmaceuticals LLC (to 8/6/2012)
Latest financial report
10-K - Q4 2022 - Mar 20, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 135 % -51.3%
Quick Ratio 44.2 % +12.6%
Debt-to-equity 1.31K % +669%
Return On Equity 25.6K %
Return On Assets -46.4 % +18%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 8.66M shares -92.2%
Common Stock, Shares, Outstanding 8.63M shares +56.7%
Entity Public Float 32.5M USD -91.4%
Common Stock, Value, Issued 9K USD +50%
Weighted Average Number of Shares Outstanding, Basic 139M shares +27.6%
Weighted Average Number of Shares Outstanding, Diluted 139M shares +27.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 103M USD +7.81%
Research and Development Expense 51.8M USD -33.4%
Operating Income (Loss) -70M USD +53.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -98.6M USD +42.3%
Income Tax Expense (Benefit) 347K USD -1820%
Net Income (Loss) Attributable to Parent -103M USD +48.2%
Earnings Per Share, Basic -0.14 USD/shares +57.6%
Earnings Per Share, Diluted -0.14 USD/shares +57.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 30.4M USD -13.5%
Accounts Receivable, after Allowance for Credit Loss, Current 27.9M USD +22.3%
Inventory, Net 42.7M USD +84.9%
Assets, Current 125M USD -6.35%
Property, Plant and Equipment, Net 1.82M USD -42.8%
Operating Lease, Right-of-Use Asset 4.22M USD -25.6%
Intangible Assets, Net (Excluding Goodwill) 72.1M USD +0.3%
Goodwill 0 USD
Other Assets, Noncurrent 804K USD -24.9%
Assets 204M USD -23.7%
Accounts Payable, Current 33.7M USD +170%
Employee-related Liabilities, Current 5.87M USD +221%
Accrued Liabilities, Current 35.4M USD +49.4%
Contract with Customer, Liability, Current 2.82M USD +0.89%
Liabilities, Current 115M USD +19.6%
Deferred Income Tax Liabilities, Net 1.75M USD 0%
Operating Lease, Liability, Noncurrent 3.05M USD -32.1%
Other Liabilities, Noncurrent 2.73M USD -10.3%
Liabilities 228M USD -2.04%
Accumulated Other Comprehensive Income (Loss), Net of Tax 887K USD
Retained Earnings (Accumulated Deficit) -1.02B USD -11.3%
Stockholders' Equity Attributable to Parent -6.51M USD -113%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -24.2M USD -170%
Liabilities and Equity 204M USD -23.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 25M shares +100%
Common Stock, Shares, Issued 8.71M shares +55.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -44M USD -171%
Interest Paid, Excluding Capitalized Interest, Operating Activities 3.79M USD -50.8%
Deferred Tax Assets, Valuation Allowance 169M USD +25.4%
Deferred Tax Assets, Gross 180M USD +23.1%
Operating Lease, Liability 5.14M USD -30.6%
Payments to Acquire Property, Plant, and Equipment 190K USD -89%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -102M USD +48.7%
Lessee, Operating Lease, Liability, to be Paid 6.22M USD -32.3%
Property, Plant and Equipment, Gross 6.28M USD -20.7%
Operating Lease, Liability, Current 2.09M USD -15.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.03M USD -6.87%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.24M USD -25.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.08M USD -39.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.47M USD -27.6%
Deferred Tax Assets, Operating Loss Carryforwards 103M USD -2.93%
Lessee, Operating Lease, Liability, to be Paid, Year Four 347K USD -76.4%
Operating Lease, Payments 846K USD -13.6%
Amortization of Intangible Assets 1.2M USD -33.3%
Depreciation, Depletion and Amortization 4.47M USD -10.7%
Deferred Tax Assets, Net of Valuation Allowance 11.6M USD -2.88%
Share-based Payment Arrangement, Expense 6.33M USD -31.3%
Interest Expense 25.8M USD +25.1%